PAMELA BROWN: Open Payments
NPI 1649734641 · CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 10 payments from 6 companies in 2025. Trend: 2023 $51 · 2024 $226 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $174 |
| Lilly USA, LLC | 3 | $156 |
| ABBVIE INC. | 1 | $23 |
| Dexcom, Inc. | 1 | $19 |
| CeQur Corporation | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: Wegovy, MOUNJARO, ZEPBOUND, LINZESS, Dexcom G6 Transmitter, CeQur Simplicity, CONTRAVE.
Industry payments across VA — which companies pay providers there.
